Trivalent CAR T cells overcome interpatient antigenic variability in glioblastoma

BACKGROUND: Glioblastoma (GBM) is the most common primary malignant brain cancer, and is currently incurable. Chimeric antigen receptor (CAR) T cells have shown promise in GBM treatment. While we have shown that combinatorial targeting of 2 glioma antigens offsets antigen escape and enhances T-cell...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Cyhoeddwyd yn:Neuro Oncol
Prif Awduron: Bielamowicz, Kevin, Fousek, Kristen, Byrd, Tiara T, Samaha, Hebatalla, Mukherjee, Malini, Aware, Nikita, Wu, Meng-Fen, Orange, Jordan S, Sumazin, Pavel, Man, Tsz-Kwong, Joseph, Sujith K, Hegde, Meenakshi, Ahmed, Nabil
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: Oxford University Press 2018
Pynciau:
Basic and Translational Investigations
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC5909636/
https://ncbi.nlm.nih.gov/pubmed/29016929
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/nox182
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg